Editorial: Women in ethnopharmacology: 2023

Gilca M, Marilena Gilca
Frontiers in pharmacology · 2024 · vol. 15 , pp. 1541890 · doi:10.3389/fphar.2024.1541890 · PMID:39834823 · PMC11743928
Other OA: gold public-domain-us
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-08 ⓘ

This 2023 editorial highlights the contributions of women in ethnopharmacology, though it does not provide specific findings or direct links to endometriosis or adenomyosis research.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-26 · read from full text ⓘ

This editorial highlights the role of women in ethnopharmacology for the year 2023, emphasizing their contributions to the field. The text serves as a declaration of no financial support, commercial conflicts of interest, or use of generative AI in the manuscript's creation. It asserts that all claims are solely those of the authors and not necessarily those of affiliated organizations or the publisher. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 795 characters · extracted from epmc-fulltextxml · 5 sections · click to expand

Author

MG: Writing–original draft, Writing–review and editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’S

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-17T06:06:14.730507+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine